Alterity Therapeutics
Alterity Therapeutics (ASX:ATH) more than doubled after its Phase 2 results, but its still only $80m
Alterity Therapeutics (ASX:ATH) hit the jackpot last week. Any clinical-stage biotech achieving a positive Phase 2 outcome is good news, because it depicts that the company's drug is not just safe, but that it works too. But while some companies (like Paradigm (ASX:PAR)) are going after markets with existing drugs that need replacement, Alterity is…
will Star Entertainment stay afloat
How much longer will Star Entertainment stay afloat? How big of a reprieve will the $60m fire sale of its events centre be?
How much longer will Star Entertainment stay afloat? By now it seems a fait accompli that Star Entertainment (ASX:SGR) will collapse - it is question of when and not if. It had a cash balance of $79m as at the close of CY24, is burning through $50m every month, its debtors have had a gutful…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here